MS Pharma
↗Amman, Jordan
MS Pharma is a leading multinational pharmaceutical company in the Middle East, North Africa, and Turkey (MENAT) region. The company specializes in the development, production, and distribution of a wide range of generic and specialty medicines, including biotech products, across therapeutic areas such as cardiovascular, central nervous system, respiratory, and oncology.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Generics and Specialty Medicines
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$500M-$1B
Founded:1989
Ownership:private
Status:operating
FUNDING
Total Raised:$95M
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Biotech/Biosimilars, Sterile injectables
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
COMPETITION
Position:Leader
Competitors:Sun Pharma, Zentiva, Menarini Group, UCB
LEADERSHIP
Key Executives:
Kalle Känd - CEO
LINKS
Website:mspharma.com
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of MS Pharma and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with MS Pharma. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.